| (Values in U.S. Thousands) | Dec, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
| Sales | 9,220 | 9,180 | 9,150 | 8,180 | 6,810 |
| Sales Growth | +0.44% | +0.33% | +11.86% | +20.12% | +46.45% |
| Net Income | -12,780 | -13,090 | -16,690 | -27,170 | -31,660 |
| Net Income Growth | +2.37% | +21.57% | +38.57% | +14.18% | -76.77% |
Aspira Women's Health Inc (AWHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Aspira Women's Health Inc. engaged in the discovery, development and commercialization of testing options and bio-analytical solutions for women's health. Aspira Women's Health Inc., formerly known as Vermillion Inc., is based in AUSTIN, Texas.
Fiscal Year End Date: 12/31